| 0 |
MEVALONATE KINASE DEFICIENCY |
8 |
0.8889 |
| 1 |
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME |
16 |
0.8889 |
| 2 |
MUCKLE-WELLS SYNDROME |
40 |
0.8163 |
| 3 |
X-LINKED LYMPHOPROLIFERATIVE SYNDROME |
24 |
0.7273 |
| 4 |
BRONCHIAL ATRESIA |
5 |
0.7143 |
| 5 |
ACTINOMYCOTIC SEPSIS |
17 |
0.6800 |
| 6 |
CHRONIC INFANTILE NEUROLOGICAL CUTANEOUS AND ARTICULAR SYNDROME |
13 |
0.6500 |
| 7 |
HYPER IGD SYNDROME |
9 |
0.6000 |
| 8 |
CRYOPYRIN ASSOCIATED PERIODIC SYNDROME |
108 |
0.5510 |
| 9 |
TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME |
27 |
0.4500 |
| 10 |
FAMILIAL MEDITERRANEAN FEVER |
82 |
0.4184 |
| 11 |
CHEMOKINE INCREASED |
11 |
0.4074 |
| 12 |
SERUM AMYLOID A PROTEIN INCREASED |
53 |
0.3419 |
| 13 |
VASCULAR COGNITIVE IMPAIRMENT |
5 |
0.2273 |
| 14 |
AUTOINFLAMMATORY DISEASE |
47 |
0.2217 |
| 15 |
INTESTINAL SEPSIS |
50 |
0.1908 |
| 16 |
SHORT STATURE |
49 |
0.1870 |
| 17 |
FAMILIAL AMYLOIDOSIS |
4 |
0.1818 |
| 18 |
PERICARDIAL CALCIFICATION |
7 |
0.1400 |
| 19 |
PERIODONTAL INFLAMMATION |
5 |
0.1316 |
| 20 |
INTERLEUKIN LEVEL INCREASED |
66 |
0.1196 |
| 21 |
HERPES ZOSTER INFECTION NEUROLOGICAL |
16 |
0.1006 |
| 22 |
SPINAL INSTABILITY |
25 |
0.0984 |
| 23 |
APPARENT DEATH |
325 |
0.0902 |
| 24 |
PULMONARY SEPTAL THICKENING |
8 |
0.0899 |
| 25 |
CLUBBING |
34 |
0.0833 |
| 26 |
VEXAS SYNDROME |
8 |
0.0833 |
| 27 |
ATLANTOAXIAL INSTABILITY |
9 |
0.0811 |
| 28 |
SECONDARY AMYLOIDOSIS |
12 |
0.0795 |
| 29 |
PNEUMONIA LIPOID |
10 |
0.0730 |
| 30 |
HYPERTENSIVE CARDIOMYOPATHY |
19 |
0.0683 |
| 31 |
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS |
8 |
0.0667 |
| 32 |
JUVENILE IDIOPATHIC ARTHRITIS |
156 |
0.0637 |
| 33 |
HYPERFERRITINAEMIA |
24 |
0.0557 |
| 34 |
EPIDURAL LIPOMATOSIS |
19 |
0.0552 |
| 35 |
PLEURAL ADHESION |
9 |
0.0450 |
| 36 |
MUSCLE ABSCESS |
27 |
0.0433 |
| 37 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
297 |
0.0395 |
| 38 |
CONGENITAL APLASIA |
12 |
0.0386 |
| 39 |
CELLULITIS STAPHYLOCOCCAL |
24 |
0.0369 |
| 40 |
HLA MARKER STUDY POSITIVE |
6 |
0.0366 |
| 41 |
JOINT ARTHROPLASTY |
61 |
0.0340 |
| 42 |
ASTEATOSIS |
4 |
0.0339 |
| 43 |
GROWTH FAILURE |
11 |
0.0320 |
| 44 |
FOCAL NODULAR HYPERPLASIA |
16 |
0.0308 |
| 45 |
STEROID DEPENDENCE |
26 |
0.0296 |
| 46 |
GROWTH RETARDATION |
85 |
0.0288 |
| 47 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
42 |
0.0278 |
| 48 |
C-REACTIVE PROTEIN ABNORMAL |
167 |
0.0260 |
| 49 |
PNEUMONIA STREPTOCOCCAL |
28 |
0.0255 |
| 50 |
ALVEOLAR PROTEINOSIS |
15 |
0.0253 |
| 51 |
SCARLET FEVER |
8 |
0.0251 |
| 52 |
HISTIOCYTOSIS HAEMATOPHAGIC |
74 |
0.0249 |
| 53 |
BLOOD CREATINE PHOSPHOKINASE DECREASED |
8 |
0.0244 |
| 54 |
DELAYED PUBERTY |
6 |
0.0236 |
| 55 |
CUSHINGOID |
75 |
0.0233 |
| 56 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
257 |
0.0232 |
| 57 |
TERMINAL STATE |
152 |
0.0227 |
| 58 |
RED BLOOD CELL SEDIMENTATION RATE |
6 |
0.0215 |
| 59 |
EXTRAVASATION BLOOD |
5 |
0.0210 |
| 60 |
PULMONARY THROMBOSIS |
211 |
0.0193 |
| 61 |
UPPER RESPIRATORY TRACT INFLAMMATION |
22 |
0.0183 |
| 62 |
CYSTITIS VIRAL |
7 |
0.0183 |
| 63 |
DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION |
4 |
0.0181 |
| 64 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1242 |
0.0174 |
| 65 |
CHONDROCALCINOSIS |
11 |
0.0168 |
| 66 |
SPONDYLOARTHROPATHY |
10 |
0.0167 |
| 67 |
SERUM FERRITIN INCREASED |
85 |
0.0161 |
| 68 |
JUVENILE ARTHRITIS |
5 |
0.0152 |
| 69 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
22 |
0.0151 |
| 70 |
HYPERPLASIA |
13 |
0.0144 |
| 71 |
COR PULMONALE ACUTE |
4 |
0.0143 |
| 72 |
JOINT ANKYLOSIS |
8 |
0.0141 |
| 73 |
AMYLOIDOSIS |
24 |
0.0139 |
| 74 |
SUPERINFECTION BACTERIAL |
11 |
0.0139 |
| 75 |
DIVERTICULITIS |
381 |
0.0137 |
| 76 |
CUTANEOUS SYMPTOM |
9 |
0.0132 |
| 77 |
STEATOHEPATITIS |
7 |
0.0131 |
| 78 |
WRIST DEFORMITY |
8 |
0.0130 |
| 79 |
OBLITERATIVE BRONCHIOLITIS |
16 |
0.0122 |
| 80 |
VARICELLA ZOSTER VIRUS INFECTION |
25 |
0.0120 |
| 81 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED |
5 |
0.0119 |
| 82 |
PNEUMONIA MYCOPLASMAL |
9 |
0.0113 |
| 83 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
26 |
0.0113 |
| 84 |
LYMPHANGITIS |
9 |
0.0112 |
| 85 |
ADENOIDAL HYPERTROPHY |
4 |
0.0106 |
| 86 |
INFECTION REACTIVATION |
12 |
0.0105 |
| 87 |
HEPATOSPLENOMEGALY |
26 |
0.0101 |
| 88 |
MENINGITIS LISTERIA |
5 |
0.0098 |
| 89 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
20 |
0.0094 |
| 90 |
CONCOMITANT DISEASE AGGRAVATED |
57 |
0.0092 |
| 91 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
47 |
0.0091 |
| 92 |
SPUTUM ABNORMAL |
6 |
0.0090 |
| 93 |
ILEAL ULCER |
9 |
0.0089 |
| 94 |
C-REACTIVE PROTEIN INCREASED |
321 |
0.0088 |
| 95 |
ROTAVIRUS INFECTION |
5 |
0.0087 |
| 96 |
INFLAMMATORY MARKER INCREASED |
42 |
0.0085 |
| 97 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
11 |
0.0084 |
| 98 |
SKIN OEDEMA |
8 |
0.0080 |
| 99 |
TONSILLITIS |
41 |
0.0078 |
| 100 |
SMALL INTESTINE ULCER |
5 |
0.0077 |
| 101 |
CONCOMITANT DISEASE PROGRESSION |
15 |
0.0077 |
| 102 |
VITILIGO |
18 |
0.0077 |
| 103 |
GENE MUTATION |
15 |
0.0076 |
| 104 |
INTESTINAL DILATATION |
10 |
0.0075 |
| 105 |
STENT PLACEMENT |
60 |
0.0074 |
| 106 |
IMPETIGO |
11 |
0.0074 |
| 107 |
EPIGLOTTITIS |
4 |
0.0074 |
| 108 |
PRODUCT SUPPLY ISSUE |
52 |
0.0073 |
| 109 |
PULMONARY VENO-OCCLUSIVE DISEASE |
5 |
0.0071 |
| 110 |
PHOTOSENSITIVITY REACTION |
117 |
0.0071 |
| 111 |
BLOOD FIBRINOGEN DECREASED |
8 |
0.0070 |
| 112 |
OTITIS MEDIA |
23 |
0.0070 |
| 113 |
SYSTEMIC MYCOSIS |
8 |
0.0068 |
| 114 |
SYMPTOM RECURRENCE |
41 |
0.0068 |
| 115 |
OTITIS MEDIA ACUTE |
5 |
0.0068 |
| 116 |
ANAEMIA OF CHRONIC DISEASE |
6 |
0.0066 |
| 117 |
PULMONARY FUNCTION TEST ABNORMAL |
10 |
0.0064 |
| 118 |
CARDIAC AMYLOIDOSIS |
7 |
0.0064 |
| 119 |
CHOLESTATIC LIVER INJURY |
14 |
0.0063 |
| 120 |
DACTYLITIS |
6 |
0.0061 |
| 121 |
AUTOIMMUNE THYROIDITIS |
23 |
0.0061 |
| 122 |
HAND-FOOT-AND-MOUTH DISEASE |
5 |
0.0060 |
| 123 |
PNEUMONIA VIRAL |
19 |
0.0060 |
| 124 |
NEPHROCALCINOSIS |
7 |
0.0059 |
| 125 |
GRAFT VERSUS HOST DISEASE IN SKIN |
13 |
0.0059 |
| 126 |
VARICELLA |
14 |
0.0059 |
| 127 |
INFECTIOUS MONONUCLEOSIS |
13 |
0.0058 |
| 128 |
NON-ALCOHOLIC STEATOHEPATITIS |
6 |
0.0058 |
| 129 |
ENTEROVIRUS INFECTION |
5 |
0.0058 |
| 130 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
16 |
0.0058 |
| 131 |
RHINOVIRUS INFECTION |
22 |
0.0056 |
| 132 |
ARTHRITIS INFECTIVE |
26 |
0.0056 |
| 133 |
BRONCHIAL WALL THICKENING |
4 |
0.0056 |
| 134 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
966 |
0.0054 |
| 135 |
OSTEOPOROTIC FRACTURE |
10 |
0.0052 |
| 136 |
BACTERIAL SEPSIS |
17 |
0.0052 |
| 137 |
DEEP VEIN THROMBOSIS |
337 |
0.0052 |
| 138 |
PHARYNGITIS STREPTOCOCCAL |
55 |
0.0051 |
| 139 |
INTERSTITIAL LUNG DISEASE |
246 |
0.0051 |
| 140 |
FAECAL CALPROTECTIN INCREASED |
16 |
0.0050 |
| 141 |
BLOOD IMMUNOGLOBULIN G INCREASED |
6 |
0.0049 |
| 142 |
LUNG OPACITY |
13 |
0.0049 |
| 143 |
SPINAL STENOSIS |
20 |
0.0048 |
| 144 |
GASTRIC DILATATION |
8 |
0.0048 |
| 145 |
VEIN DISORDER |
24 |
0.0048 |
| 146 |
TONSILLAR HYPERTROPHY |
8 |
0.0048 |
| 147 |
POLYARTHRITIS |
25 |
0.0047 |
| 148 |
KNEE DEFORMITY |
7 |
0.0047 |
| 149 |
IMMUNE THROMBOCYTOPENIA |
21 |
0.0046 |
| 150 |
INFECTION SUSCEPTIBILITY INCREASED |
10 |
0.0046 |
| 151 |
PSEUDOMONAL SEPSIS |
8 |
0.0046 |
| 152 |
BLOOD ALBUMIN INCREASED |
4 |
0.0045 |
| 153 |
BONE CYST |
4 |
0.0043 |
| 154 |
NORMAL NEWBORN |
23 |
0.0042 |
| 155 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
16 |
0.0042 |
| 156 |
GASTROENTERITIS |
61 |
0.0042 |
| 157 |
SUBCUTANEOUS ABSCESS |
20 |
0.0042 |
| 158 |
PYREXIA |
1442 |
0.0042 |
| 159 |
ADRENAL DISORDER |
8 |
0.0042 |
| 160 |
STREPTOCOCCAL INFECTION |
23 |
0.0041 |
| 161 |
ENTERITIS INFECTIOUS |
7 |
0.0041 |
| 162 |
PULMONARY EMBOLISM |
391 |
0.0041 |
| 163 |
CONTRAINDICATED PRODUCT ADMINISTERED |
124 |
0.0041 |
| 164 |
INFLAMMATORY BOWEL DISEASE |
40 |
0.0041 |
| 165 |
JOINT SWELLING |
492 |
0.0041 |
| 166 |
TYPE IV HYPERSENSITIVITY REACTION |
11 |
0.0040 |
| 167 |
EPSTEIN-BARR VIRUS INFECTION |
25 |
0.0040 |
| 168 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
5 |
0.0040 |
| 169 |
BUTTERFLY RASH |
4 |
0.0039 |
| 170 |
HEPATIC STEATOSIS |
73 |
0.0039 |
| 171 |
PYODERMA GANGRENOSUM |
14 |
0.0039 |
| 172 |
JOINT EFFUSION |
26 |
0.0038 |
| 173 |
ALLERGY TO ANIMAL |
4 |
0.0038 |
| 174 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
6 |
0.0037 |
| 175 |
WRONG DOSE |
9 |
0.0037 |
| 176 |
LYMPHADENITIS |
9 |
0.0037 |
| 177 |
HAND FRACTURE |
26 |
0.0037 |
| 178 |
NASAL DISCHARGE DISCOLOURATION |
5 |
0.0036 |
| 179 |
DISCHARGE |
5 |
0.0036 |
| 180 |
OESOPHAGEAL CANDIDIASIS |
14 |
0.0035 |
| 181 |
PHYSICAL DECONDITIONING |
9 |
0.0035 |
| 182 |
OSTEOPENIA |
53 |
0.0035 |
| 183 |
KIDNEY FIBROSIS |
6 |
0.0035 |
| 184 |
SARS-COV-2 TEST POSITIVE |
45 |
0.0034 |
| 185 |
BONE EROSION |
12 |
0.0034 |
| 186 |
CAPILLARY LEAK SYNDROME |
7 |
0.0034 |
| 187 |
CREPITATIONS |
10 |
0.0034 |
| 188 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
53 |
0.0033 |
| 189 |
ATYPICAL PNEUMONIA |
10 |
0.0033 |
| 190 |
ENTEROCOLITIS |
19 |
0.0033 |
| 191 |
SINUS NODE DYSFUNCTION |
6 |
0.0033 |
| 192 |
HEPATOMEGALY |
32 |
0.0033 |
| 193 |
INFLAMMATION |
168 |
0.0033 |
| 194 |
ARTHROPOD BITE |
24 |
0.0032 |
| 195 |
LYMPHADENOPATHY |
113 |
0.0032 |
| 196 |
HERPES ZOSTER |
180 |
0.0031 |
| 197 |
CLOSTRIDIUM DIFFICILE COLITIS |
33 |
0.0031 |
| 198 |
SPLENOMEGALY |
36 |
0.0031 |
| 199 |
EXPOSURE VIA FATHER |
4 |
0.0031 |
| 200 |
CYTOMEGALOVIRUS COLITIS |
7 |
0.0030 |
| 201 |
DEAFNESS NEUROSENSORY |
10 |
0.0030 |
| 202 |
KNEE ARTHROPLASTY |
64 |
0.0030 |
| 203 |
BODY TEMPERATURE INCREASED |
62 |
0.0030 |
| 204 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
78 |
0.0030 |
| 205 |
CYTOPENIA |
37 |
0.0030 |
| 206 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
13 |
0.0029 |
| 207 |
WOUND INFECTION |
32 |
0.0029 |
| 208 |
FAILURE TO THRIVE |
15 |
0.0029 |
| 209 |
CONDITION AGGRAVATED |
876 |
0.0029 |
| 210 |
HYPERTRANSAMINASAEMIA |
20 |
0.0029 |
| 211 |
THROMBOSIS |
231 |
0.0029 |
| 212 |
INTRACRANIAL PRESSURE INCREASED |
16 |
0.0029 |
| 213 |
RENAL FAILURE |
380 |
0.0029 |
| 214 |
PHARYNGEAL ERYTHEMA |
6 |
0.0028 |
| 215 |
NEUTROPHIL COUNT ABNORMAL |
8 |
0.0028 |
| 216 |
ATYPICAL MYCOBACTERIAL INFECTION |
4 |
0.0028 |
| 217 |
FIBRIN D DIMER INCREASED |
10 |
0.0028 |
| 218 |
RESPIRATORY SYMPTOM |
8 |
0.0028 |
| 219 |
ILLNESS |
289 |
0.0028 |
| 220 |
SEPSIS |
308 |
0.0028 |
| 221 |
SKIN PAPILLOMA |
11 |
0.0027 |
| 222 |
CUTANEOUS VASCULITIS |
10 |
0.0027 |
| 223 |
VIRAL INFECTION |
91 |
0.0027 |
| 224 |
CONJUNCTIVITIS ALLERGIC |
4 |
0.0027 |
| 225 |
PLEURISY |
16 |
0.0027 |
| 226 |
BK VIRUS INFECTION |
9 |
0.0027 |
| 227 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
6 |
0.0027 |
| 228 |
PHARYNGITIS |
33 |
0.0027 |
| 229 |
CHRONIC GASTRITIS |
6 |
0.0027 |
| 230 |
ASTIGMATISM |
4 |
0.0026 |
| 231 |
ARTHROPATHY |
146 |
0.0026 |
| 232 |
EAR INFECTION |
69 |
0.0026 |
| 233 |
CORONAVIRUS INFECTION |
17 |
0.0026 |
| 234 |
STOMATITIS |
155 |
0.0026 |
| 235 |
DECREASED IMMUNE RESPONSIVENESS |
25 |
0.0025 |
| 236 |
MULTI-ORGAN DISORDER |
5 |
0.0025 |
| 237 |
MACULE |
7 |
0.0025 |
| 238 |
PARONYCHIA |
11 |
0.0025 |
| 239 |
CELLULITIS |
126 |
0.0025 |
| 240 |
PULMONARY HYPERTENSION |
51 |
0.0024 |
| 241 |
PAPILLOEDEMA |
11 |
0.0024 |
| 242 |
GASTROINTESTINAL PERFORATION |
10 |
0.0024 |
| 243 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
24 |
0.0024 |
| 244 |
UPPER RESPIRATORY TRACT INFECTION |
110 |
0.0024 |
| 245 |
ALANINE AMINOTRANSFERASE ABNORMAL |
5 |
0.0024 |
| 246 |
ARTHRITIS |
184 |
0.0023 |
| 247 |
ACUTE SINUSITIS |
4 |
0.0023 |
| 248 |
SKIN INFECTION |
26 |
0.0023 |
| 249 |
DEPRESSION SUICIDAL |
8 |
0.0023 |
| 250 |
MENINGITIS |
15 |
0.0022 |
| 251 |
INCORRECT DOSE ADMINISTERED |
506 |
0.0022 |
| 252 |
LOSS OF THERAPEUTIC RESPONSE |
7 |
0.0022 |
| 253 |
OSTEOPOROSIS |
90 |
0.0022 |
| 254 |
RHINORRHOEA |
140 |
0.0022 |
| 255 |
SYNOVIAL CYST |
10 |
0.0022 |
| 256 |
BREAKTHROUGH PAIN |
5 |
0.0022 |
| 257 |
PUSTULE |
5 |
0.0021 |
| 258 |
RHINITIS |
17 |
0.0021 |
| 259 |
ANXIETY DISORDER |
7 |
0.0021 |
| 260 |
LYMPHOCYTE COUNT DECREASED |
37 |
0.0021 |
| 261 |
PERICARDITIS |
35 |
0.0021 |
| 262 |
ADENOVIRUS INFECTION |
6 |
0.0021 |
| 263 |
PANNICULITIS |
5 |
0.0021 |
| 264 |
INFLUENZA |
229 |
0.0021 |
| 265 |
THERAPY PARTIAL RESPONDER |
32 |
0.0020 |
| 266 |
PRODUCT DISTRIBUTION ISSUE |
19 |
0.0020 |
| 267 |
ANAL ABSCESS |
11 |
0.0020 |
| 268 |
BODY TEMPERATURE DECREASED |
20 |
0.0020 |
| 269 |
EMPYEMA |
4 |
0.0020 |
| 270 |
HEPATIC CYTOLYSIS |
25 |
0.0020 |
| 271 |
INJECTION SITE EXTRAVASATION |
24 |
0.0019 |
| 272 |
STAPHYLOCOCCAL INFECTION |
64 |
0.0019 |
| 273 |
GASTROENTERITIS VIRAL |
35 |
0.0019 |
| 274 |
LUNG DISORDER |
95 |
0.0019 |
| 275 |
IMMUNOSUPPRESSION |
17 |
0.0019 |
| 276 |
SARCOIDOSIS |
9 |
0.0019 |
| 277 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
9 |
0.0019 |
| 278 |
TRANSAMINASES INCREASED |
42 |
0.0019 |
| 279 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
5 |
0.0019 |
| 280 |
DISEASE RECURRENCE |
89 |
0.0019 |
| 281 |
DRUG RESISTANCE |
48 |
0.0019 |
| 282 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
7 |
0.0019 |
| 283 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
102 |
0.0019 |
| 284 |
MOUTH ULCERATION |
39 |
0.0018 |
| 285 |
INTENTIONAL PRODUCT USE ISSUE |
161 |
0.0018 |
| 286 |
SUSPECTED COVID-19 |
6 |
0.0018 |
| 287 |
URTICARIA |
303 |
0.0018 |
| 288 |
PROCTITIS |
5 |
0.0018 |
| 289 |
MENINGITIS ASEPTIC |
8 |
0.0018 |
| 290 |
CONJUNCTIVITIS |
33 |
0.0018 |
| 291 |
COVID-19 |
312 |
0.0018 |
| 292 |
POSTOPERATIVE WOUND INFECTION |
12 |
0.0018 |
| 293 |
UVEITIS |
24 |
0.0018 |
| 294 |
NASAL CONGESTION |
102 |
0.0017 |
| 295 |
ANGINA UNSTABLE |
11 |
0.0017 |
| 296 |
OCULAR DISCOMFORT |
19 |
0.0017 |
| 297 |
FOOT FRACTURE |
32 |
0.0017 |
| 298 |
CONJUNCTIVAL HYPERAEMIA |
6 |
0.0017 |
| 299 |
EYE INFLAMMATION |
16 |
0.0017 |
| 300 |
APHTHOUS ULCER |
13 |
0.0017 |
| 301 |
MALAISE |
731 |
0.0017 |
| 302 |
DRUG INTOLERANCE |
160 |
0.0017 |
| 303 |
BONE MARROW DISORDER |
5 |
0.0017 |
| 304 |
HIDRADENITIS |
15 |
0.0016 |
| 305 |
QUALITY OF LIFE DECREASED |
22 |
0.0016 |
| 306 |
AUTISM SPECTRUM DISORDER |
9 |
0.0016 |
| 307 |
PARADOXICAL DRUG REACTION |
6 |
0.0016 |
| 308 |
ABSCESS |
26 |
0.0016 |
| 309 |
MULTIPLE-DRUG RESISTANCE |
5 |
0.0016 |
| 310 |
CARDIAC DYSFUNCTION |
6 |
0.0016 |
| 311 |
HAEMOGLOBIN DECREASED |
165 |
0.0016 |
| 312 |
SPINAL FRACTURE |
32 |
0.0016 |
| 313 |
ERYSIPELAS |
8 |
0.0016 |
| 314 |
BLOOD PRESSURE SYSTOLIC INCREASED |
31 |
0.0016 |
| 315 |
OROPHARYNGEAL PAIN |
146 |
0.0016 |
| 316 |
RHINITIS ALLERGIC |
7 |
0.0016 |
| 317 |
EOSINOPHIL COUNT INCREASED |
13 |
0.0016 |
| 318 |
EOSINOPHILIA |
27 |
0.0015 |
| 319 |
PAIN |
946 |
0.0015 |
| 320 |
WOUND SECRETION |
6 |
0.0015 |
| 321 |
SKIN LESION |
42 |
0.0015 |
| 322 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
26 |
0.0015 |
| 323 |
NEAR DEATH EXPERIENCE |
5 |
0.0015 |
| 324 |
UTERINE LEIOMYOMA |
11 |
0.0015 |
| 325 |
LYME DISEASE |
5 |
0.0015 |
| 326 |
DEAFNESS |
39 |
0.0015 |
| 327 |
SPINAL DISORDER |
14 |
0.0015 |
| 328 |
ARTHRALGIA |
613 |
0.0015 |
| 329 |
TOOTH ABSCESS |
15 |
0.0015 |
| 330 |
HYDRONEPHROSIS |
11 |
0.0015 |
| 331 |
THERAPY NON-RESPONDER |
66 |
0.0015 |
| 332 |
HYPERURICAEMIA |
6 |
0.0015 |
| 333 |
INFECTION |
211 |
0.0015 |
| 334 |
ACUTE CORONARY SYNDROME |
12 |
0.0014 |
| 335 |
OBESITY |
23 |
0.0014 |
| 336 |
EAR PAIN |
28 |
0.0014 |
| 337 |
NEURALGIA |
35 |
0.0014 |
| 338 |
AUTOIMMUNE DISORDER |
14 |
0.0014 |
| 339 |
PRODUCT LEAKAGE |
8 |
0.0014 |
| 340 |
RESPIRATORY TRACT INFECTION |
37 |
0.0014 |
| 341 |
BREATH SOUNDS ABNORMAL |
7 |
0.0014 |
| 342 |
PAPULE |
10 |
0.0014 |
| 343 |
IMMUNODEFICIENCY |
21 |
0.0014 |
| 344 |
NEUTROPHILIA |
8 |
0.0014 |
| 345 |
ENTERITIS |
9 |
0.0014 |
| 346 |
PSEUDOMONAS INFECTION |
12 |
0.0014 |
| 347 |
MYOCARDITIS |
16 |
0.0014 |
| 348 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
10 |
0.0014 |
| 349 |
APPENDICITIS |
13 |
0.0014 |
| 350 |
SPONDYLITIS |
5 |
0.0014 |
| 351 |
HYPOGAMMAGLOBULINAEMIA |
9 |
0.0014 |
| 352 |
PRODUCT USE IN UNAPPROVED INDICATION |
337 |
0.0014 |
| 353 |
IMMUNE-MEDIATED ENTEROCOLITIS |
5 |
0.0014 |
| 354 |
ILEUS PARALYTIC |
6 |
0.0013 |
| 355 |
NASOPHARYNGITIS |
247 |
0.0013 |
| 356 |
SCRATCH |
14 |
0.0013 |
| 357 |
PRODUCT STORAGE ERROR |
116 |
0.0013 |
| 358 |
INJECTION SITE VESICLES |
8 |
0.0013 |
| 359 |
ADRENAL INSUFFICIENCY |
16 |
0.0013 |
| 360 |
TROPONIN INCREASED |
10 |
0.0013 |
| 361 |
SYRINGE ISSUE |
23 |
0.0013 |
| 362 |
RASH |
571 |
0.0013 |
| 363 |
SKIN PLAQUE |
11 |
0.0013 |
| 364 |
DUODENITIS |
4 |
0.0013 |
| 365 |
HAEMOLYSIS |
10 |
0.0013 |
| 366 |
BRONCHOPULMONARY ASPERGILLOSIS |
10 |
0.0013 |
| 367 |
INFUSION SITE EXTRAVASATION |
8 |
0.0013 |
| 368 |
LOCALISED INFECTION |
31 |
0.0013 |
| 369 |
PRODUCT AVAILABILITY ISSUE |
29 |
0.0013 |
| 370 |
NEEDLE ISSUE |
37 |
0.0013 |
| 371 |
OSTEOMYELITIS |
23 |
0.0013 |
| 372 |
PYELONEPHRITIS |
11 |
0.0013 |
| 373 |
BRAIN OEDEMA |
16 |
0.0013 |
| 374 |
ABDOMINAL PAIN |
288 |
0.0012 |
| 375 |
RESPIRATORY DISORDER |
37 |
0.0012 |
| 376 |
THERAPEUTIC RESPONSE SHORTENED |
41 |
0.0012 |
| 377 |
HEPATITIS ACUTE |
8 |
0.0012 |
| 378 |
DEMYELINATION |
5 |
0.0012 |
| 379 |
ILL-DEFINED DISORDER |
74 |
0.0012 |
| 380 |
WOUND |
34 |
0.0012 |
| 381 |
STAPHYLOCOCCAL SEPSIS |
6 |
0.0012 |
| 382 |
ANAPHYLACTOID REACTION |
5 |
0.0012 |
| 383 |
FRACTURE |
23 |
0.0012 |
| 384 |
INJECTION SITE INFLAMMATION |
6 |
0.0012 |
| 385 |
SKIN WARM |
7 |
0.0012 |
| 386 |
FLUID INTAKE REDUCED |
6 |
0.0012 |
| 387 |
PNEUMONIA BACTERIAL |
11 |
0.0012 |
| 388 |
HYPERTRIGLYCERIDAEMIA |
7 |
0.0012 |
| 389 |
COUGH |
335 |
0.0012 |
| 390 |
ATRIAL SEPTAL DEFECT |
10 |
0.0012 |
| 391 |
PRODUCT ADMINISTRATION ERROR |
24 |
0.0012 |
| 392 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
5 |
0.0012 |
| 393 |
BRONCHIECTASIS |
8 |
0.0012 |
| 394 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
21 |
0.0012 |
| 395 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
6 |
0.0012 |
| 396 |
DRUG DISPENSING ERROR |
18 |
0.0012 |
| 397 |
ESCHERICHIA URINARY TRACT INFECTION |
5 |
0.0012 |
| 398 |
ABSCESS LIMB |
5 |
0.0012 |
| 399 |
LIVER FUNCTION TEST INCREASED |
25 |
0.0012 |
| 400 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
11 |
0.0012 |
| 401 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
10 |
0.0011 |
| 402 |
SENSITIVITY TO WEATHER CHANGE |
6 |
0.0011 |
| 403 |
SKIN DISORDER |
38 |
0.0011 |
| 404 |
BRONCHIOLITIS |
4 |
0.0011 |
| 405 |
PRODUCT PRESCRIBING ERROR |
27 |
0.0011 |
| 406 |
ABDOMINAL ABSCESS |
5 |
0.0011 |
| 407 |
LYMPHOPENIA |
16 |
0.0011 |
| 408 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
25 |
0.0011 |
| 409 |
BLOOD DISORDER |
9 |
0.0011 |
| 410 |
RENAL TUBULAR NECROSIS |
11 |
0.0011 |
| 411 |
FOOD POISONING |
6 |
0.0011 |
| 412 |
GASTROINTESTINAL INFECTION |
10 |
0.0011 |
| 413 |
GINGIVITIS |
6 |
0.0011 |
| 414 |
EAR DISORDER |
5 |
0.0011 |
| 415 |
ASPARTATE AMINOTRANSFERASE INCREASED |
58 |
0.0011 |
| 416 |
IRON DEFICIENCY ANAEMIA |
10 |
0.0011 |
| 417 |
PERICARDIAL EFFUSION |
25 |
0.0011 |
| 418 |
BRONCHITIS |
80 |
0.0011 |
| 419 |
LEUKOPENIA |
54 |
0.0011 |
| 420 |
INTERCEPTED MEDICATION ERROR |
5 |
0.0011 |
| 421 |
BACTERIAL INFECTION |
20 |
0.0011 |
| 422 |
IMMUNE SYSTEM DISORDER |
14 |
0.0011 |
| 423 |
HEPATIC ENZYME INCREASED |
72 |
0.0011 |
| 424 |
TENDERNESS |
11 |
0.0011 |
| 425 |
PNEUMONIA |
338 |
0.0010 |
| 426 |
INJECTION SITE RASH |
32 |
0.0010 |
| 427 |
JOINT DISLOCATION |
11 |
0.0010 |
| 428 |
SKIN SWELLING |
9 |
0.0010 |
| 429 |
PULMONARY ARTERIAL HYPERTENSION |
15 |
0.0010 |
| 430 |
RALES |
6 |
0.0010 |
| 431 |
THROMBOTIC MICROANGIOPATHY |
10 |
0.0010 |
| 432 |
ALANINE AMINOTRANSFERASE INCREASED |
63 |
0.0010 |
| 433 |
CATARACT |
61 |
0.0010 |
| 434 |
INCORRECT DOSAGE ADMINISTERED |
5 |
0.0010 |
| 435 |
GLUCOSE TOLERANCE IMPAIRED |
6 |
0.0010 |
| 436 |
LIGAMENT SPRAIN |
10 |
0.0010 |
| 437 |
LOW BIRTH WEIGHT BABY |
8 |
0.0010 |
| 438 |
ODYNOPHAGIA |
6 |
0.0010 |
| 439 |
CEREBRAL ATROPHY |
4 |
0.0010 |
| 440 |
MATERNAL EXPOSURE DURING PREGNANCY |
89 |
0.0010 |
| 441 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
6 |
0.0010 |
| 442 |
HEPATITIS |
25 |
0.0010 |
| 443 |
NEUTROPHIL COUNT INCREASED |
10 |
0.0010 |
| 444 |
CARDIOMEGALY |
12 |
0.0010 |
| 445 |
ENDOCARDITIS |
5 |
0.0010 |
| 446 |
ARTHRITIS BACTERIAL |
4 |
0.0010 |
| 447 |
HYPOKINESIA |
14 |
0.0010 |
| 448 |
PRODUCT DISPENSING ERROR |
21 |
0.0010 |
| 449 |
PRODUCTIVE COUGH |
46 |
0.0010 |
| 450 |
MYOCARDIAL INFARCTION |
168 |
0.0010 |
| 451 |
FEELING ABNORMAL |
228 |
0.0010 |
| 452 |
DRUG INEFFECTIVE |
1242 |
0.0009 |
| 453 |
RASH ERYTHEMATOUS |
45 |
0.0009 |
| 454 |
WHITE BLOOD CELL COUNT INCREASED |
36 |
0.0009 |
| 455 |
NECK PAIN |
52 |
0.0009 |
| 456 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
26 |
0.0009 |
| 457 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
65 |
0.0009 |
| 458 |
DEAFNESS UNILATERAL |
5 |
0.0009 |
| 459 |
HAEMATOCHEZIA |
50 |
0.0009 |
| 460 |
DENTAL CARIES |
10 |
0.0009 |
| 461 |
BLOOD CREATINE INCREASED |
4 |
0.0009 |
| 462 |
GENERAL PHYSICAL CONDITION ABNORMAL |
6 |
0.0009 |
| 463 |
GASTROINTESTINAL DISORDER |
79 |
0.0009 |
| 464 |
CHILLS |
103 |
0.0009 |
| 465 |
DISEASE COMPLICATION |
4 |
0.0009 |
| 466 |
BLOOD PRESSURE DIASTOLIC INCREASED |
4 |
0.0009 |
| 467 |
LARGE INTESTINE PERFORATION |
6 |
0.0009 |
| 468 |
OCULAR HYPERAEMIA |
41 |
0.0009 |
| 469 |
AUTOIMMUNE HEPATITIS |
6 |
0.0009 |
| 470 |
OFF LABEL USE |
751 |
0.0009 |
| 471 |
TREATMENT FAILURE |
71 |
0.0009 |
| 472 |
FLANK PAIN |
8 |
0.0009 |
| 473 |
HEPATIC CIRRHOSIS |
16 |
0.0009 |
| 474 |
ESCHERICHIA INFECTION |
7 |
0.0009 |
| 475 |
PALLOR |
23 |
0.0008 |
| 476 |
PLATELET COUNT INCREASED |
11 |
0.0008 |
| 477 |
CYTOMEGALOVIRUS INFECTION |
14 |
0.0008 |
| 478 |
FEAR OF INJECTION |
6 |
0.0008 |
| 479 |
COAGULOPATHY |
14 |
0.0008 |
| 480 |
IMPAIRED QUALITY OF LIFE |
12 |
0.0008 |
| 481 |
GLAUCOMA |
16 |
0.0008 |
| 482 |
HEART RATE DECREASED |
29 |
0.0008 |
| 483 |
MELAENA |
18 |
0.0008 |
| 484 |
COLITIS |
31 |
0.0008 |
| 485 |
MYALGIA |
139 |
0.0008 |
| 486 |
HEPATOTOXICITY |
18 |
0.0008 |
| 487 |
PNEUMONITIS |
22 |
0.0008 |
| 488 |
GENERALISED OEDEMA |
10 |
0.0008 |
| 489 |
SCOLIOSIS |
5 |
0.0008 |
| 490 |
NIGHT SWEATS |
26 |
0.0008 |
| 491 |
INTESTINAL PERFORATION |
9 |
0.0008 |
| 492 |
NEPHROPATHY TOXIC |
9 |
0.0008 |
| 493 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
21 |
0.0008 |
| 494 |
NAIL DISORDER |
7 |
0.0008 |
| 495 |
SECRETION DISCHARGE |
10 |
0.0008 |
| 496 |
BLEPHAROSPASM |
5 |
0.0008 |
| 497 |
PURPURA |
7 |
0.0008 |
| 498 |
HYPOMAGNESAEMIA |
11 |
0.0008 |
| 499 |
RESPIRATORY RATE INCREASED |
7 |
0.0008 |
| 500 |
FACIAL PAIN |
7 |
0.0008 |
| 501 |
SKIN REACTION |
11 |
0.0008 |
| 502 |
HEPATOCELLULAR INJURY |
11 |
0.0008 |
| 503 |
CONCUSSION |
6 |
0.0008 |
| 504 |
VASCULITIS |
9 |
0.0008 |
| 505 |
PERITONITIS |
16 |
0.0008 |
| 506 |
HERPES SIMPLEX |
5 |
0.0008 |
| 507 |
FOLLICULITIS |
8 |
0.0008 |
| 508 |
COVID-19 PNEUMONIA |
9 |
0.0008 |
| 509 |
HYPERTENSION |
161 |
0.0008 |
| 510 |
BACTERAEMIA |
9 |
0.0008 |
| 511 |
FURUNCLE |
6 |
0.0008 |
| 512 |
CHOLECYSTITIS |
9 |
0.0008 |
| 513 |
GINGIVAL PAIN |
6 |
0.0008 |
| 514 |
SINUSITIS |
77 |
0.0008 |
| 515 |
HEPATIC FUNCTION ABNORMAL |
28 |
0.0007 |
| 516 |
JOINT INJURY |
16 |
0.0007 |
| 517 |
ASCITES |
22 |
0.0007 |
| 518 |
GAIT INABILITY |
25 |
0.0007 |
| 519 |
SWELLING |
70 |
0.0007 |
| 520 |
LIVER DISORDER |
33 |
0.0007 |
| 521 |
DISEASE PROGRESSION |
88 |
0.0007 |
| 522 |
HYPOACUSIS |
32 |
0.0007 |
| 523 |
THROMBOCYTOPENIA |
83 |
0.0007 |
| 524 |
DECREASED ACTIVITY |
8 |
0.0007 |
| 525 |
PROTEINURIA |
14 |
0.0007 |
| 526 |
BLOOD TRIGLYCERIDES INCREASED |
13 |
0.0007 |
| 527 |
INJECTION SITE REACTION |
50 |
0.0007 |
| 528 |
MUSCULOSKELETAL STIFFNESS |
63 |
0.0007 |
| 529 |
ORAL HERPES |
14 |
0.0007 |
| 530 |
APHONIA |
10 |
0.0007 |
| 531 |
PHARYNGEAL SWELLING |
7 |
0.0007 |
| 532 |
MOBILITY DECREASED |
51 |
0.0007 |
| 533 |
HEADACHE |
445 |
0.0007 |
| 534 |
STATUS EPILEPTICUS |
8 |
0.0007 |
| 535 |
FLUID RETENTION |
36 |
0.0007 |
| 536 |
MUSCULOSKELETAL PAIN |
37 |
0.0007 |
| 537 |
RASH PRURITIC |
38 |
0.0007 |
| 538 |
WEIGHT INCREASED |
157 |
0.0007 |
| 539 |
AGRANULOCYTOSIS |
13 |
0.0007 |
| 540 |
HYPERSOMNIA |
20 |
0.0007 |
| 541 |
HYPOTHERMIA |
7 |
0.0007 |
| 542 |
FEEDING DISORDER |
14 |
0.0007 |
| 543 |
FAECES SOFT |
5 |
0.0007 |
| 544 |
INCORRECT PRODUCT STORAGE |
9 |
0.0007 |
| 545 |
GASTRITIS |
18 |
0.0007 |
| 546 |
TOOTH INFECTION |
9 |
0.0007 |
| 547 |
PAIN IN EXTREMITY |
201 |
0.0007 |
| 548 |
HELICOBACTER INFECTION |
7 |
0.0007 |
| 549 |
ERYTHEMA |
140 |
0.0007 |
| 550 |
THERAPEUTIC RESPONSE DECREASED |
41 |
0.0007 |
| 551 |
PRESCRIBED OVERDOSE |
13 |
0.0007 |
| 552 |
PULMONARY OEDEMA |
30 |
0.0007 |
| 553 |
ANAPHYLACTIC REACTION |
37 |
0.0007 |
| 554 |
MYOSITIS |
6 |
0.0007 |
| 555 |
SEPTIC SHOCK |
29 |
0.0007 |
| 556 |
OROPHARYNGEAL DISCOMFORT |
6 |
0.0007 |
| 557 |
CHEST PAIN |
123 |
0.0007 |
| 558 |
LIMB INJURY |
18 |
0.0007 |
| 559 |
KIDNEY INFECTION |
13 |
0.0007 |
| 560 |
URINARY TRACT INFECTION |
113 |
0.0007 |
| 561 |
RESPIRATORY FAILURE |
48 |
0.0007 |
| 562 |
HYPOTHYROIDISM |
21 |
0.0007 |
| 563 |
VOMITING |
308 |
0.0007 |
| 564 |
HYPERTHERMIA |
5 |
0.0007 |
| 565 |
RETINAL DETACHMENT |
6 |
0.0007 |
| 566 |
CANDIDA INFECTION |
11 |
0.0007 |
| 567 |
UROSEPSIS |
6 |
0.0006 |
| 568 |
MUCOSAL INFLAMMATION |
17 |
0.0006 |
| 569 |
JOINT STIFFNESS |
17 |
0.0006 |
| 570 |
SWELLING FACE |
42 |
0.0006 |
| 571 |
MASS |
9 |
0.0006 |
| 572 |
LETHARGY |
37 |
0.0006 |
| 573 |
HYPOALBUMINAEMIA |
5 |
0.0006 |
| 574 |
DIARRHOEA HAEMORRHAGIC |
6 |
0.0006 |
| 575 |
TACHYCARDIA |
57 |
0.0006 |
| 576 |
GASTROINTESTINAL INFLAMMATION |
5 |
0.0006 |
| 577 |
GASTROINTESTINAL PAIN |
7 |
0.0006 |
| 578 |
LEUKAEMIA |
6 |
0.0006 |
| 579 |
RHEUMATOID ARTHRITIS |
72 |
0.0006 |
| 580 |
SPUTUM DISCOLOURED |
6 |
0.0006 |
| 581 |
PRODUCT USE ISSUE |
118 |
0.0006 |
| 582 |
ABORTION SPONTANEOUS |
25 |
0.0006 |
| 583 |
RENAL DISORDER |
29 |
0.0006 |
| 584 |
ATELECTASIS |
6 |
0.0006 |
| 585 |
DRUG ADMINISTRATION ERROR |
19 |
0.0006 |
| 586 |
BLOOD PRESSURE DECREASED |
41 |
0.0006 |
| 587 |
PRODUCT DOSE OMISSION ISSUE |
181 |
0.0006 |
| 588 |
VITAMIN D DEFICIENCY |
6 |
0.0006 |
| 589 |
POST PROCEDURAL INFECTION |
5 |
0.0006 |
| 590 |
BONE PAIN |
36 |
0.0006 |
| 591 |
NEUTROPHIL COUNT DECREASED |
25 |
0.0006 |
| 592 |
NODULE |
8 |
0.0006 |
| 593 |
LIVER INJURY |
15 |
0.0006 |
| 594 |
ENCEPHALOPATHY |
15 |
0.0006 |
| 595 |
ASPERGILLUS INFECTION |
4 |
0.0006 |
| 596 |
LEUKOCYTOSIS |
11 |
0.0006 |
| 597 |
VERTIGO |
37 |
0.0006 |
| 598 |
CRYING |
22 |
0.0006 |
| 599 |
CARDIAC FAILURE ACUTE |
4 |
0.0006 |
| 600 |
SPINAL PAIN |
7 |
0.0006 |
| 601 |
ABDOMINAL PAIN UPPER |
123 |
0.0006 |
| 602 |
TACHYPNOEA |
8 |
0.0006 |
| 603 |
SLUGGISHNESS |
6 |
0.0006 |
| 604 |
FACIAL PARALYSIS |
5 |
0.0006 |
| 605 |
LYMPHOMA |
9 |
0.0006 |
| 606 |
MUSCULOSKELETAL CHEST PAIN |
9 |
0.0006 |
| 607 |
TEMPERATURE INTOLERANCE |
6 |
0.0006 |
| 608 |
WHITE BLOOD CELL COUNT DECREASED |
63 |
0.0006 |
| 609 |
ORAL PAIN |
13 |
0.0006 |
| 610 |
IMPAIRED HEALING |
19 |
0.0006 |
| 611 |
ENCEPHALITIS |
4 |
0.0006 |
| 612 |
MUSCLE STRAIN |
5 |
0.0006 |
| 613 |
PETECHIAE |
6 |
0.0006 |
| 614 |
NEUTROPENIA |
78 |
0.0006 |
| 615 |
PANCYTOPENIA |
32 |
0.0006 |
| 616 |
CYANOSIS |
9 |
0.0006 |
| 617 |
ACUTE RESPIRATORY FAILURE |
11 |
0.0006 |
| 618 |
INFLUENZA LIKE ILLNESS |
47 |
0.0006 |
| 619 |
GROIN PAIN |
5 |
0.0006 |
| 620 |
LUNG INFILTRATION |
5 |
0.0006 |
| 621 |
RENAL PAIN |
6 |
0.0006 |
| 622 |
HAEMORRHOIDS |
11 |
0.0006 |
| 623 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
14 |
0.0006 |
| 624 |
EATING DISORDER |
12 |
0.0006 |
| 625 |
DIVERTICULUM |
4 |
0.0006 |
| 626 |
MOVEMENT DISORDER |
18 |
0.0006 |
| 627 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
4 |
0.0006 |
| 628 |
BLOOD BILIRUBIN INCREASED |
15 |
0.0006 |
| 629 |
ECZEMA |
29 |
0.0006 |
| 630 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
12 |
0.0006 |
| 631 |
DEVICE DISLOCATION |
24 |
0.0006 |
| 632 |
VENTRICULAR TACHYCARDIA |
9 |
0.0005 |
| 633 |
HYPOXIA |
19 |
0.0005 |
| 634 |
HYPERTENSIVE CRISIS |
6 |
0.0005 |
| 635 |
FEELING COLD |
15 |
0.0005 |
| 636 |
DUODENAL ULCER PERFORATION |
4 |
0.0005 |
| 637 |
MALNUTRITION |
6 |
0.0005 |
| 638 |
SNEEZING |
12 |
0.0005 |
| 639 |
MIGRAINE |
51 |
0.0005 |
| 640 |
BLISTER |
30 |
0.0005 |
| 641 |
ORAL CANDIDIASIS |
7 |
0.0005 |
| 642 |
ARTERIOSCLEROSIS |
5 |
0.0005 |
| 643 |
REBOUND EFFECT |
6 |
0.0005 |
| 644 |
INJECTION SITE URTICARIA |
13 |
0.0005 |
| 645 |
ANAEMIA |
101 |
0.0005 |
| 646 |
SEIZURE |
61 |
0.0005 |
| 647 |
INFUSION RELATED REACTION |
35 |
0.0005 |
| 648 |
PLEURAL EFFUSION |
32 |
0.0005 |
| 649 |
BACK PAIN |
121 |
0.0005 |
| 650 |
GENERAL PHYSICAL HEALTH DETERIORATION |
60 |
0.0005 |
| 651 |
FOOD ALLERGY |
4 |
0.0005 |
| 652 |
OEDEMA |
28 |
0.0005 |
| 653 |
DYSURIA |
19 |
0.0005 |
| 654 |
ABDOMINAL PAIN LOWER |
13 |
0.0005 |
| 655 |
FATIGUE |
400 |
0.0005 |
| 656 |
BASAL CELL CARCINOMA |
8 |
0.0005 |
| 657 |
HYPERHIDROSIS |
66 |
0.0005 |
| 658 |
INJECTION SITE SWELLING |
39 |
0.0005 |
| 659 |
AFFECTIVE DISORDER |
4 |
0.0005 |
| 660 |
FAECES DISCOLOURED |
11 |
0.0005 |
| 661 |
LOWER RESPIRATORY TRACT INFECTION |
23 |
0.0005 |
| 662 |
ACCIDENT |
6 |
0.0005 |
| 663 |
SKIN DISCOLOURATION |
23 |
0.0005 |
| 664 |
BURSITIS |
6 |
0.0005 |
| 665 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
22 |
0.0005 |
| 666 |
MOTOR DYSFUNCTION |
5 |
0.0005 |
| 667 |
PARALYSIS |
7 |
0.0005 |
| 668 |
ANGINA PECTORIS |
14 |
0.0005 |
| 669 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
14 |
0.0005 |
| 670 |
MYELODYSPLASTIC SYNDROME |
7 |
0.0005 |
| 671 |
CYST |
6 |
0.0005 |
| 672 |
JAUNDICE |
13 |
0.0005 |
| 673 |
PSYCHOMOTOR HYPERACTIVITY |
8 |
0.0005 |
| 674 |
PERIPHERAL SWELLING |
74 |
0.0005 |
| 675 |
GASTROINTESTINAL HAEMORRHAGE |
40 |
0.0005 |
| 676 |
WEIGHT FLUCTUATION |
5 |
0.0005 |
| 677 |
FEELING HOT |
29 |
0.0005 |
| 678 |
RESPIRATORY DISTRESS |
13 |
0.0005 |
| 679 |
HYPOPHAGIA |
12 |
0.0005 |
| 680 |
PULMONARY FIBROSIS |
9 |
0.0005 |
| 681 |
FEBRILE NEUTROPENIA |
31 |
0.0005 |
| 682 |
RASH GENERALISED |
12 |
0.0005 |
| 683 |
DIARRHOEA |
296 |
0.0005 |
| 684 |
PULMONARY CONGESTION |
6 |
0.0005 |
| 685 |
DEVICE RELATED INFECTION |
7 |
0.0005 |
| 686 |
MENTAL IMPAIRMENT |
11 |
0.0005 |
| 687 |
PRESYNCOPE |
11 |
0.0005 |
| 688 |
RASH MACULO-PAPULAR |
10 |
0.0004 |
| 689 |
RASH PAPULAR |
10 |
0.0004 |
| 690 |
GOUT |
8 |
0.0004 |
| 691 |
DYSSTASIA |
13 |
0.0004 |
| 692 |
TOOTHACHE |
8 |
0.0004 |
| 693 |
PNEUMOTHORAX |
7 |
0.0004 |
| 694 |
LABORATORY TEST ABNORMAL |
13 |
0.0004 |
| 695 |
ULCER |
7 |
0.0004 |
| 696 |
PREMATURE DELIVERY |
7 |
0.0004 |
| 697 |
INJECTION SITE HAEMORRHAGE |
35 |
0.0004 |
| 698 |
EXOSTOSIS |
4 |
0.0004 |
| 699 |
PERIPHERAL COLDNESS |
6 |
0.0004 |
| 700 |
HYPERSENSITIVITY |
81 |
0.0004 |
| 701 |
MEDICATION ERROR |
24 |
0.0004 |
| 702 |
GAIT DISTURBANCE |
82 |
0.0004 |
| 703 |
BLOOD TEST ABNORMAL |
6 |
0.0004 |
| 704 |
DISSEMINATED INTRAVASCULAR COAGULATION |
6 |
0.0004 |
| 705 |
EYE PAIN |
24 |
0.0004 |
| 706 |
PHOTOPHOBIA |
8 |
0.0004 |
| 707 |
INTESTINAL OBSTRUCTION |
16 |
0.0004 |
| 708 |
SEASONAL ALLERGY |
6 |
0.0004 |
| 709 |
FUNGAL INFECTION |
14 |
0.0004 |
| 710 |
MUSCLE RIGIDITY |
5 |
0.0004 |
| 711 |
BLOOD UREA INCREASED |
7 |
0.0004 |
| 712 |
DRUG PRESCRIBING ERROR |
8 |
0.0004 |
| 713 |
PLATELET COUNT DECREASED |
44 |
0.0004 |
| 714 |
CLOSTRIDIUM DIFFICILE INFECTION |
9 |
0.0004 |
| 715 |
WEIGHT DECREASED |
115 |
0.0004 |
| 716 |
CIRCULATORY COLLAPSE |
7 |
0.0004 |
| 717 |
NO THERAPEUTIC RESPONSE |
5 |
0.0004 |
| 718 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
12 |
0.0004 |
| 719 |
HAEMATURIA |
14 |
0.0004 |
| 720 |
MOOD SWINGS |
13 |
0.0004 |
| 721 |
HAEMATOCRIT DECREASED |
8 |
0.0004 |
| 722 |
PULMONARY MASS |
6 |
0.0004 |
| 723 |
INJECTION SITE BRUISING |
32 |
0.0004 |
| 724 |
AGEUSIA |
10 |
0.0004 |
| 725 |
BRAIN INJURY |
4 |
0.0004 |
| 726 |
DYSPNOEA EXERTIONAL |
15 |
0.0004 |
| 727 |
SUICIDE ATTEMPT |
24 |
0.0004 |
| 728 |
BLOOD COUNT ABNORMAL |
6 |
0.0004 |
| 729 |
INJECTION SITE PAIN |
121 |
0.0004 |
| 730 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
14 |
0.0004 |
| 731 |
INSURANCE ISSUE |
6 |
0.0004 |
| 732 |
INJECTION SITE WARMTH |
8 |
0.0004 |
| 733 |
INJECTION SITE PRURITUS |
26 |
0.0004 |
| 734 |
LIMB DISCOMFORT |
12 |
0.0004 |
| 735 |
HAEMATOMA |
10 |
0.0004 |
| 736 |
INJECTION SITE INDURATION |
5 |
0.0004 |
| 737 |
ROAD TRAFFIC ACCIDENT |
16 |
0.0004 |
| 738 |
PRURITUS |
145 |
0.0004 |
| 739 |
DYSMENORRHOEA |
5 |
0.0004 |
| 740 |
ADVERSE REACTION |
5 |
0.0004 |
| 741 |
CYSTITIS |
12 |
0.0004 |
| 742 |
HEART RATE INCREASED |
37 |
0.0004 |
| 743 |
RASH MACULAR |
13 |
0.0004 |
| 744 |
SKIN IRRITATION |
17 |
0.0004 |
| 745 |
DEVICE LEAKAGE |
16 |
0.0004 |
| 746 |
BLOOD URINE PRESENT |
7 |
0.0004 |
| 747 |
PRODUCT PRESCRIBING ISSUE |
8 |
0.0004 |
| 748 |
SLEEP APNOEA SYNDROME |
7 |
0.0004 |
| 749 |
ACUTE KIDNEY INJURY |
56 |
0.0004 |
| 750 |
CHOLELITHIASIS |
12 |
0.0004 |
| 751 |
OSTEONECROSIS |
12 |
0.0004 |
| 752 |
HEPATIC FAILURE |
11 |
0.0004 |
| 753 |
BLOOD PRESSURE INCREASED |
55 |
0.0004 |
| 754 |
CHOKING |
7 |
0.0004 |
| 755 |
UNDERDOSE |
26 |
0.0004 |
| 756 |
EYE INFECTION |
4 |
0.0004 |
| 757 |
WHEEZING |
21 |
0.0004 |
| 758 |
CONTUSION |
34 |
0.0004 |
| 759 |
NERVOUS SYSTEM DISORDER |
11 |
0.0004 |
| 760 |
DEHYDRATION |
47 |
0.0004 |
| 761 |
BLOOD PRESSURE ABNORMAL |
7 |
0.0004 |
| 762 |
ABDOMINAL DISCOMFORT |
59 |
0.0004 |
| 763 |
PRESCRIBED UNDERDOSE |
7 |
0.0004 |
| 764 |
SUBDURAL HAEMATOMA |
5 |
0.0003 |
| 765 |
NEPHROLITHIASIS |
16 |
0.0003 |
| 766 |
MUSCULOSKELETAL DISCOMFORT |
6 |
0.0003 |
| 767 |
CARDIOGENIC SHOCK |
5 |
0.0003 |
| 768 |
ANOSMIA |
5 |
0.0003 |
| 769 |
ABDOMINAL DISTENSION |
36 |
0.0003 |
| 770 |
BURNING SENSATION |
24 |
0.0003 |
| 771 |
ASTHENIA |
128 |
0.0003 |
| 772 |
DRUG EFFECT LESS THAN EXPECTED |
5 |
0.0003 |
| 773 |
CARDIAC FAILURE |
27 |
0.0003 |
| 774 |
COLITIS ULCERATIVE |
15 |
0.0003 |
| 775 |
COLON CANCER |
5 |
0.0003 |
| 776 |
HAEMORRHAGE |
35 |
0.0003 |
| 777 |
SYNOVITIS |
6 |
0.0003 |
| 778 |
CARDIAC DISORDER |
31 |
0.0003 |
| 779 |
LIP SWELLING |
11 |
0.0003 |
| 780 |
OSTEOARTHRITIS |
14 |
0.0003 |
| 781 |
MOOD ALTERED |
9 |
0.0003 |
| 782 |
SYNCOPE |
33 |
0.0003 |
| 783 |
ABNORMAL BEHAVIOUR |
13 |
0.0003 |
| 784 |
DISCOMFORT |
20 |
0.0003 |
| 785 |
EPILEPSY |
10 |
0.0003 |
| 786 |
IRRITABLE BOWEL SYNDROME |
7 |
0.0003 |
| 787 |
ABASIA |
8 |
0.0003 |
| 788 |
ANXIETY |
92 |
0.0003 |
| 789 |
NAUSEA |
254 |
0.0003 |
| 790 |
ACCIDENTAL EXPOSURE TO PRODUCT |
33 |
0.0003 |
| 791 |
SWOLLEN TONGUE |
10 |
0.0003 |
| 792 |
BRAIN FOG |
5 |
0.0003 |
| 793 |
DRUG-INDUCED LIVER INJURY |
10 |
0.0003 |
| 794 |
ACNE |
24 |
0.0003 |
| 795 |
DYSPNOEA |
179 |
0.0003 |
| 796 |
GASTRIC ULCER |
6 |
0.0003 |
| 797 |
INSOMNIA |
84 |
0.0003 |
| 798 |
MUSCULOSKELETAL DISORDER |
6 |
0.0003 |
| 799 |
INCREASED APPETITE |
6 |
0.0003 |
| 800 |
SCIATICA |
5 |
0.0003 |
| 801 |
PANCREATITIS ACUTE |
7 |
0.0003 |
| 802 |
ANAPHYLACTIC SHOCK |
8 |
0.0003 |
| 803 |
FOETAL EXPOSURE DURING PREGNANCY |
25 |
0.0003 |
| 804 |
EPISTAXIS |
23 |
0.0003 |
| 805 |
DECREASED APPETITE |
71 |
0.0003 |
| 806 |
SPEECH DISORDER |
16 |
0.0003 |
| 807 |
EYE DISORDER |
10 |
0.0003 |
| 808 |
DRUG EFFECT INCOMPLETE |
11 |
0.0003 |
| 809 |
GENERALISED TONIC-CLONIC SEIZURE |
5 |
0.0003 |
| 810 |
UPPER LIMB FRACTURE |
6 |
0.0003 |
| 811 |
PREMATURE BABY |
9 |
0.0003 |
| 812 |
INJECTION SITE ERYTHEMA |
37 |
0.0003 |
| 813 |
FULL BLOOD COUNT DECREASED |
6 |
0.0003 |
| 814 |
ACUTE HEPATIC FAILURE |
4 |
0.0003 |
| 815 |
CENTRAL NERVOUS SYSTEM LESION |
4 |
0.0003 |
| 816 |
PALPITATIONS |
34 |
0.0003 |
| 817 |
DIABETES MELLITUS |
22 |
0.0003 |
| 818 |
FIBROMYALGIA |
7 |
0.0003 |
| 819 |
HAEMOPTYSIS |
8 |
0.0003 |
| 820 |
LOCAL SWELLING |
5 |
0.0003 |
| 821 |
DERMATITIS |
6 |
0.0003 |
| 822 |
METASTASES TO LIVER |
5 |
0.0003 |
| 823 |
PANCREATITIS |
15 |
0.0003 |
| 824 |
COLD SWEAT |
5 |
0.0003 |
| 825 |
HEAD DISCOMFORT |
5 |
0.0003 |
| 826 |
MUSCULAR WEAKNESS |
32 |
0.0003 |
| 827 |
BRONCHOSPASM |
4 |
0.0003 |
| 828 |
CEREBRAL HAEMORRHAGE |
10 |
0.0003 |
| 829 |
DIZZINESS |
139 |
0.0003 |
| 830 |
CARDIOVASCULAR DISORDER |
7 |
0.0003 |
| 831 |
PELVIC PAIN |
5 |
0.0003 |
| 832 |
FLUID OVERLOAD |
4 |
0.0003 |
| 833 |
HYPERGLYCAEMIA |
10 |
0.0003 |
| 834 |
END STAGE RENAL DISEASE |
5 |
0.0003 |
| 835 |
ANGIOEDEMA |
12 |
0.0003 |
| 836 |
INJECTION SITE MASS |
10 |
0.0003 |
| 837 |
URINARY INCONTINENCE |
8 |
0.0003 |
| 838 |
THROAT IRRITATION |
12 |
0.0003 |
| 839 |
OXYGEN SATURATION DECREASED |
15 |
0.0003 |
| 840 |
LOWER LIMB FRACTURE |
5 |
0.0003 |
| 841 |
DELIRIUM |
9 |
0.0003 |
| 842 |
GYNAECOMASTIA |
8 |
0.0003 |
| 843 |
HYPERKALAEMIA |
9 |
0.0003 |
| 844 |
DYSPHONIA |
15 |
0.0003 |
| 845 |
FALL |
85 |
0.0003 |
| 846 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
9 |
0.0003 |
| 847 |
IRRITABILITY |
15 |
0.0002 |
| 848 |
CYTOKINE RELEASE SYNDROME |
5 |
0.0002 |
| 849 |
NERVOUSNESS |
13 |
0.0002 |
| 850 |
CONSTIPATION |
54 |
0.0002 |
| 851 |
PAIN IN JAW |
7 |
0.0002 |
| 852 |
BLOOD POTASSIUM INCREASED |
4 |
0.0002 |
| 853 |
BONE MARROW FAILURE |
5 |
0.0002 |
| 854 |
PRODUCT DOSE OMISSION |
16 |
0.0002 |
| 855 |
HYPOTENSION |
49 |
0.0002 |
| 856 |
PRODUCT PREPARATION ERROR |
5 |
0.0002 |
| 857 |
LOSS OF CONSCIOUSNESS |
31 |
0.0002 |
| 858 |
VISUAL ACUITY REDUCED |
8 |
0.0002 |
| 859 |
LIVER FUNCTION TEST ABNORMAL |
7 |
0.0002 |
| 860 |
PNEUMONIA ASPIRATION |
6 |
0.0002 |
| 861 |
HOT FLUSH |
18 |
0.0002 |
| 862 |
WITHDRAWAL SYNDROME |
10 |
0.0002 |
| 863 |
RENAL IMPAIRMENT |
20 |
0.0002 |
| 864 |
OEDEMA PERIPHERAL |
29 |
0.0002 |
| 865 |
FACE OEDEMA |
4 |
0.0002 |
| 866 |
SKIN EXFOLIATION |
20 |
0.0002 |
| 867 |
HAEMATEMESIS |
6 |
0.0002 |
| 868 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
47 |
0.0002 |
| 869 |
LACRIMATION INCREASED |
7 |
0.0002 |
| 870 |
VAGINAL HAEMORRHAGE |
10 |
0.0002 |
| 871 |
MENTAL DISORDER |
10 |
0.0002 |
| 872 |
DEVICE USE ISSUE |
4 |
0.0002 |
| 873 |
DISORIENTATION |
9 |
0.0002 |
| 874 |
HYPOGLYCAEMIA |
11 |
0.0002 |
| 875 |
BRADYCARDIA |
12 |
0.0002 |
| 876 |
EYE IRRITATION |
13 |
0.0002 |
| 877 |
TOOTH DISORDER |
5 |
0.0002 |
| 878 |
CHEST DISCOMFORT |
23 |
0.0002 |
| 879 |
PAIN OF SKIN |
6 |
0.0002 |
| 880 |
DRUG EFFECT DECREASED |
12 |
0.0002 |
| 881 |
HEART RATE IRREGULAR |
5 |
0.0002 |
| 882 |
BONE DISORDER |
4 |
0.0002 |
| 883 |
ALOPECIA |
43 |
0.0002 |
| 884 |
VISUAL IMPAIRMENT |
27 |
0.0002 |
| 885 |
TINNITUS |
10 |
0.0002 |
| 886 |
HIP FRACTURE |
7 |
0.0002 |
| 887 |
SHOCK |
5 |
0.0002 |
| 888 |
ADVERSE EVENT |
20 |
0.0002 |
| 889 |
MENTAL STATUS CHANGES |
6 |
0.0002 |
| 890 |
ATRIAL FIBRILLATION |
21 |
0.0002 |
| 891 |
EYE SWELLING |
8 |
0.0002 |
| 892 |
BLOOD CHOLESTEROL INCREASED |
10 |
0.0002 |
| 893 |
INCORRECT DRUG ADMINISTRATION DURATION |
6 |
0.0002 |
| 894 |
ASTHMA |
24 |
0.0002 |
| 895 |
ARRHYTHMIA |
10 |
0.0002 |
| 896 |
RED BLOOD CELL COUNT DECREASED |
6 |
0.0002 |
| 897 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
7 |
0.0002 |
| 898 |
ANGER |
7 |
0.0002 |
| 899 |
BLOOD CREATININE INCREASED |
13 |
0.0002 |
| 900 |
SLEEP DISORDER |
14 |
0.0002 |
| 901 |
PSORIATIC ARTHROPATHY |
8 |
0.0002 |
| 902 |
FLUSHING |
20 |
0.0002 |
| 903 |
BLINDNESS |
8 |
0.0002 |
| 904 |
NEOPLASM MALIGNANT |
13 |
0.0002 |
| 905 |
EMOTIONAL DISORDER |
6 |
0.0002 |
| 906 |
DEPRESSION |
44 |
0.0002 |
| 907 |
RHABDOMYOLYSIS |
8 |
0.0002 |
| 908 |
DEATH |
165 |
0.0002 |
| 909 |
CARDIO-RESPIRATORY ARREST |
8 |
0.0002 |
| 910 |
HEAD INJURY |
6 |
0.0002 |
| 911 |
NO ADVERSE EVENT |
34 |
0.0002 |
| 912 |
METABOLIC ACIDOSIS |
6 |
0.0002 |
| 913 |
HYPOAESTHESIA |
28 |
0.0002 |
| 914 |
GASTROOESOPHAGEAL REFLUX DISEASE |
15 |
0.0002 |
| 915 |
PARAESTHESIA |
29 |
0.0002 |
| 916 |
PSORIASIS |
24 |
0.0002 |
| 917 |
DEMENTIA |
5 |
0.0002 |
| 918 |
THERAPEUTIC RESPONSE UNEXPECTED |
8 |
0.0002 |
| 919 |
TYPE 2 DIABETES MELLITUS |
6 |
0.0002 |
| 920 |
ADVERSE DRUG REACTION |
16 |
0.0002 |
| 921 |
TOXICITY TO VARIOUS AGENTS |
30 |
0.0002 |
| 922 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
9 |
0.0002 |
| 923 |
COMA |
8 |
0.0002 |
| 924 |
THERAPY INTERRUPTED |
12 |
0.0002 |
| 925 |
BLOOD PRESSURE FLUCTUATION |
4 |
0.0002 |
| 926 |
DIABETIC KETOACIDOSIS |
4 |
0.0002 |
| 927 |
BLOOD POTASSIUM DECREASED |
5 |
0.0002 |
| 928 |
CORONARY ARTERY DISEASE |
5 |
0.0002 |
| 929 |
PANIC ATTACK |
6 |
0.0002 |
| 930 |
RECTAL HAEMORRHAGE |
7 |
0.0002 |
| 931 |
DYSPHAGIA |
15 |
0.0002 |
| 932 |
MUSCLE SPASMS |
29 |
0.0002 |
| 933 |
DEVICE ISSUE |
14 |
0.0002 |
| 934 |
SUICIDAL IDEATION |
14 |
0.0002 |
| 935 |
DERMATITIS ATOPIC |
8 |
0.0002 |
| 936 |
DEPRESSED MOOD |
8 |
0.0002 |
| 937 |
BALANCE DISORDER |
13 |
0.0002 |
| 938 |
URINARY RETENTION |
5 |
0.0001 |
| 939 |
AGITATION |
11 |
0.0001 |
| 940 |
DYSKINESIA |
6 |
0.0001 |
| 941 |
CEREBROVASCULAR ACCIDENT |
25 |
0.0001 |
| 942 |
LUNG NEOPLASM MALIGNANT |
6 |
0.0001 |
| 943 |
CARDIAC ARREST |
12 |
0.0001 |
| 944 |
DYSPEPSIA |
14 |
0.0001 |
| 945 |
SOMNOLENCE |
28 |
0.0001 |
| 946 |
VISION BLURRED |
19 |
0.0001 |
| 947 |
AMNESIA |
9 |
0.0001 |
| 948 |
HOSPITALISATION |
21 |
0.0001 |
| 949 |
THERAPY CESSATION |
7 |
0.0001 |
| 950 |
DYSARTHRIA |
5 |
0.0001 |
| 951 |
TREMOR |
22 |
0.0001 |
| 952 |
APHASIA |
4 |
0.0001 |
| 953 |
HYPOKALAEMIA |
6 |
0.0001 |
| 954 |
FEMUR FRACTURE |
4 |
0.0001 |
| 955 |
TREATMENT NONCOMPLIANCE |
7 |
0.0001 |
| 956 |
CONVULSION |
7 |
0.0001 |
| 957 |
POLLAKIURIA |
5 |
0.0001 |
| 958 |
OVERDOSE |
25 |
0.0001 |
| 959 |
DEVICE MALFUNCTION |
8 |
0.0001 |
| 960 |
MULTIPLE SCLEROSIS RELAPSE |
7 |
0.0001 |
| 961 |
DRUG INTERACTION |
16 |
0.0001 |
| 962 |
EXTRA DOSE ADMINISTERED |
4 |
0.0001 |
| 963 |
DRY MOUTH |
8 |
0.0001 |
| 964 |
DRY SKIN |
13 |
0.0001 |
| 965 |
BREAST CANCER |
9 |
0.0001 |
| 966 |
CHRONIC KIDNEY DISEASE |
7 |
0.0001 |
| 967 |
MEMORY IMPAIRMENT |
12 |
0.0001 |
| 968 |
CARDIAC FAILURE CONGESTIVE |
7 |
0.0001 |
| 969 |
COGNITIVE DISORDER |
4 |
0.0001 |
| 970 |
BLOOD GLUCOSE INCREASED |
16 |
0.0001 |
| 971 |
NEUROPATHY PERIPHERAL |
8 |
0.0001 |
| 972 |
BLOOD GLUCOSE DECREASED |
4 |
0.0001 |
| 973 |
EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 974 |
HALLUCINATION |
6 |
0.0001 |
| 975 |
INJURY |
5 |
0.0001 |
| 976 |
DYSGEUSIA |
5 |
0.0001 |
| 977 |
PRODUCT QUALITY ISSUE |
9 |
0.0001 |
| 978 |
UNEVALUABLE EVENT |
5 |
0.0001 |
| 979 |
DRUG DOSE OMISSION BY DEVICE |
5 |
0.0001 |
| 980 |
DRUG DEPENDENCE |
10 |
0.0001 |
| 981 |
MALIGNANT NEOPLASM PROGRESSION |
5 |
0.0000 |
| 982 |
DRUG DOSE OMISSION |
7 |
0.0000 |
| 983 |
EMOTIONAL DISTRESS |
5 |
0.0000 |
| 984 |
CONFUSIONAL STATE |
5 |
0.0000 |